Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 4 7Phase 1 7Phase NA 6Phase 1/2 4Phase 2/3 3Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other solid neoplasm 1

Conditions

Stomatitis 1Small Cell Lung Carcinoma 1Peripheral Nervous System Diseases 1Ototoxicity 1Mesothelioma 1Drug-Induced Nephropathy 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Interventional × Acetylcysteine × Clear all
NCT07391163 2026-02-10

Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

Tanta University

Phase NA Completed
46 enrolled
Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT07082621 2025-07-24

N Acetylcystene in Treatment of Radiotherapy Induced Oral Mucositis in Oral Cancer Patients

Alexandria University

Phase NA Completed
40 enrolled

Stomatitis

NCT06122311 2024-07-05

Drug Nephrotoxicity Amelioration by N-acetylcysteine

Helwan University

Phase NA Completed
100 enrolled

Drug-Induced Nephropathy

NCT06039280 2023-09-15

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Institute of Liver and Biliary Sciences, India

Phase NA Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00637624 2022-08-25

NAC-PNP

Rijnstate Hospital

Phase NA Terminated
69 enrolled
Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Small Cell Lung Carcinoma

NCT03400709 2018-01-17

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Hospital San Juan de Dios, Santiago

Phase NA Completed
45 enrolled

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡